UK markets open in 3 hours 2 minutes
NIKKEI 225
37,726.04 -734.04 (-1.91%) HANG SENG
17,294.47 +93.20 (+0.54%) CRUDE OIL
82.86 +0.05 (+0.06%) GOLD FUTURES
2,324.30 -14.10 (-0.60%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,596.21 -1,829.81 (-3.42%)
Ekso Bionics Holdings, Inc. (EKSO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 21.13M |
| Enterprise value | 19.66M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.90 |
| Price/book (mrq) | 1.68 |
| Enterprise value/revenue | 1.08 |
| Enterprise value/EBITDA | -1.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.64 |
| 52-week change 3 | -18.06% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 3.1290 |
| 52-week low 3 | 0.6200 |
| 50-day moving average 3 | 1.5494 |
| 200-day moving average 3 | 1.4043 |
Share statistics
| Avg vol (3-month) 3 | 167.35k |
| Avg vol (10-day) 3 | 128.06k |
| Shares outstanding 5 | 17.9M |
| Implied shares outstanding 6 | 17.9M |
| Float 8 | 16.01M |
| % held by insiders 1 | 13.50% |
| % held by institutions 1 | 7.61% |
| Shares short (28 Mar 2024) 4 | 134.27k |
| Short ratio (28 Mar 2024) 4 | 0.55 |
| Short % of float (28 Mar 2024) 4 | 0.78% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.75% |
| Shares short (prior month 29 Feb 2024) 4 | 145.05k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 Mar 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 25 Mar 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -83.14% |
| Operating margin (ttm) | -71.16% |
Management effectiveness
| Return on assets (ttm) | -27.06% |
| Return on equity (ttm) | -79.89% |
Income statement
| Revenue (ttm) | 18.28M |
| Revenue per share (ttm) | 1.32 |
| Quarterly revenue growth (yoy) | 36.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -13.41M |
| Net income avi to common (ttm) | -15.2M |
| Diluted EPS (ttm) | -1.1200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 8.64M |
| Total cash per share (mrq) | 0.48 |
| Total debt (mrq) | 7.17M |
| Total debt/equity (mrq) | 56.86% |
| Current ratio (mrq) | 2.49 |
| Book value per share (mrq) | 0.85 |
Cash flow statement
| Operating cash flow (ttm) | -12.05M |
| Levered free cash flow (ttm) | -6.96M |
© 2024 Yahoo. All rights reserved.